Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02010593 · ClinicalTrials.gov registry record · Phase 2
Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal Women
A Phase 2 study, sponsored by International Partnership for Microbicides.
- Completed
- Registry status
- Phase 2
- Development phase
- 96
- Enrollment target
NCT02010593: Completed Phase 2 study, sponsored by International Partnership for Microbicides.
NCT02010593 is a Phase 2 study that has completed, run by International Partnership for Microbicides. The registered enrollment target is 96 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (28% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02010593, a Phase 2 study, has completed, sponsored by International Partnership for Microbicides.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 96 participants
- Enrollment target
Study Summary
This study will evaluate the safety of the dapivirine vaginal ring when inserts once every 4 weeks in postmenopausal women over 12 weeks of product use.
Primary Outcome
Evidence of Grade 2 or higher genital, genitourinary and reproductive system AEs as defined by the Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events, Version 1.0, Dec 2004 (Clarification dated August 2009), Addendum 1, (Female Genital Grading Table for Use in Microbicide Studies) judged to be related to study product. Evidence of Grade 3 or higher AEs as defined by the Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events, Vers
Interventions
- DRUG Dapivirine Vaginal Ring
- DRUG Placebo Vaginal Ring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-04 |
| Phase | Phase 2 |
What the finished NCT02010593 record still lists
NCT02010593 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (28% lower).
The record links to 0 conditions, and to 2 interventions - of which Dapivirine Vaginal Ring is the first listed.
NCT02010593 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02010593 about?
NCT02010593 is a clinical study titled "Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal Women". This study will evaluate the safety of the dapivirine vaginal ring when inserts once every 4 weeks in postmenopausal women over 12 weeks of product use.
What is the current status of trial NCT02010593?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 96 participants. The study started on 2013-12. Estimated completion is 2015-04.
What interventions are being tested in trial NCT02010593?
The interventions under investigation include: Dapivirine Vaginal Ring (DRUG), Placebo Vaginal Ring (DRUG).
Who is sponsoring clinical trial NCT02010593?
This trial is sponsored by International Partnership for Microbicides, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02010593's enrollment target sits among peer trials
96 747th of 2000 higher than 1,242 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia